NYSE : RDY

Dr. Reddy's Laboratories Limited

Healthcare · Drug Manufacturers - Specialty & Generic · India

Last price 14.11 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 11.81B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as ...